A Delaware judge this week ordered formal submissions from both Unilife (NSDQ:UNIS) and Insulet (NSDQ:PODD) as the companies fought over Unilife’s Chapter 11 bankruptcy sale, with Insulet claiming Unilife is selectively refusing to supply appropriate information and restricting it’s ability to participate.
Insulet claims that Unilife has not provided it with enough data to make an informed bid on the assets, and has specifically targeted the company in its refusals, even after it signed a non disclosure agreement in May.
Read the whole story on our sister site, Drug Delivery Business News.